Abstract:A virus infection can be initiated with very few or even a single infectious virion, and as such can become extinct, i.e. stochastically fail to take hold or spread significantly. There are many ways that a fully competent infectious virion, having successfully entered a cell, can fail to cause a productive infection, i.e. one that yields infectious virus progeny. Though many discrete, stochastic mathematical models (DSMs) have been developed and used to estimate a virus infection's extinction probability, these typically neglect infection failure post viral entry. The DSM presented herein introduces parameter $\gamma\in(0,1]$ which corresponds to the probability that a virion's entry into a cell will result in a productive cell infection. We derive an expression for the likelihood of infection extinction in this new DSM, and find that prophylactic therapy with an antiviral acting to reduce $\gamma$ is best at increasing an infection's extinction probability, compared to antivirals acting on the rates of virus production or virus entry into cells. Using the DSM, we investigate the difference in the fraction of cells consumed by so-called extinct versus established virus infections, and find that this distinction becomes biologically meaningless as the probability of extinction approaches 100%. We show that infections wherein virus is release by an infected cell as a single burst, rather than at a constant rate over the cell's infectious lifespan, has the same probability of infection extinction, despite previous claims to this effect [Pearson 2011, doi:<a class="link-https link-external" data-doi="10.1371/journal.pcbi.1001058" href="https://doi.org/10.1371/journal.pcbi.1001058" rel="external noopener nofollow">https://doi.org/10.1371/journal.pcbi.1001058</a>]. Instead, extending previous work by others [Yan 2016, doi:<a class="link-https link-external" data-doi="10.1007/s00285-015-0961-5" href="https://doi.org/10.1007/s00285-015-0961-5" rel="external noopener nofollow">https://doi.org/10.1007/s00285-015-0961-5</a>], we show how the assumed distribution for the stochastic virus burst size, affects the extinction probability and associated critical antiviral efficacy.

Viral evolution under the pressure of an adaptive immune system - optimal mutation rates for viral escape

Transient evolutionary epidemiology of viral adaptation and lethal mutagenesis

Evolutionary stability of antigenically escaping viruses

Mutational Load Causes Stochastic Evolutionary Outcomes in Acute RNA Viral Infection

Pulse Instabilities Can Shape Virus-Immune Co-evolution

The Route of HIV Escape from Immune Response Targeting Multiple Sites Is Determined by the Cost-Benefit Tradeoff of Escape Mutations

Eco-evolutionary dynamics of adapting pathogens and host immunity

Large Evolutionary Rate Heterogeneity among and within HIV-1 Subtypes and CRFs

Recombination Rate and Selection Strength in HIV Intra-patient Evolution

Evolution into chaos – implications of the trade-off between transmissibility and immune evasion

Within-host evolution of SARS-CoV-2: how often are de novo mutations transmitted from symptomatic infections?

Mathematical modeling of escape of HIV from cytotoxic T lymphocyte responses

Mutation rate variability as a driving force in adaptive evolution

Endogenous viral mutations, evolutionary selection, and containment policy design

Costs and Benefits of Mutational Robustness in RNA Viruses.

Eco-evolutionary constraints for the endemicity of rapidly evolving viruses

Multi-lineage evolution in viral populations driven by host immune systems

Stochastic failure of cell infection post viral entry: Implications for infection outcomes and antiviral therapy

Host-Parasite Co-evolution and Optimal Mutation Rates for Semi-conservative Quasispecies

Evolutionary Game Theoretic Strategy for Optimal Drug Delivery to Influence Selection Pressure in Treatment of HIV-1

Selection and Neutral Mutations Drive Pervasive Mutability Losses in Long-Lived Anti-HIV B-Cell Lineages